Evaluation of the combined extract of <i>Rauwolfia vomitoria</i> and <i>Aframomum melegueta</i> on the kidney and liver of adult male Wistar rats

Phytomedicine, also known as herbal medicine, has seen a great upsurge globally. It refers to the use of plants, herbs, and mixtures of well-known plant metabolites to cure and mitigate human diseases. They are often used because they are natural and therefore assumed to be safer than allopathic medicines. In recent times, however, there has been a growing concern about their safety. This study aimed to evaluate the combined effect of methanolic extract of Rauwolfia vomitoria and Aframomum melegueta on renal and liver morphology of experimental animals with respect to the expression of Interleukin 10 (IL-10) and nuclear factor erythroid 2-related factor 2 (NRF2). Twenty adults male Wistar rats weighing 180-230 g were grouped into four consisting of a control and three test groups. While the control rats were administered with distilled water only, the rats in groups II and III were singly administered with methanolic extracts of Rauwolfia vomitoria and Aframomum melegueta at standard doses of 250 mg/kg/BW respectively while rats in group IV were co-administered with the methanolic extracts of Rauwolfia vomitoria and Aframomum melegueta at 250 mg/kg/BW respectively. At the end of the experiment, the rats were euthanized, and the kidneys and livers were analyzed for histological and mRNA analysis. Histopathological findings revealed no cytopathic lesions on the renal and liver morphology across all groups while mRNA expression studies indicated the anti-inflammatory and antioxidant effects of the plants by upregulating the expression of IL-10 and Nrf-2 in the treated groups. The administration of the leaf extracts of Rauwolfia vomitoria and Aframomum melegueta at a dosage of 250 mg/kg/BW has no cytopathic effects on the kidney and liver morphology of Wistar rats with the co-administrative extract treatment better upregulating the expression of IL-10 and NRF-2 than single administration in the treated rats thus indicating its antioxidative potential and safety of usage and further validating their use in traditional medical practice.

Authors

Publication Details

Journal
Sokoto Journal of Medical Laboratory Science
Published
2024-12-06
DOI
https://doi.org/10.4314/sokjmls.v9i2.24
Citations
3
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the combined extract of Rauwolfia vomitoria and Aframomum melegueta on the kidney and liver of adult male Wistar rats

Akinpelu Moronkeji, Temidayo Adeniyi, Omokehinde Oseni Akinlami, Firdaws Oriade Alaga et al.
3 citations
Sokoto Journal of Medical Laboratory Science
Drug-Induced Hepatotoxicity and Protection
1.40
article

Evaluation of the combined extract of Rauwolfia vomitoria and Aframomum melegueta on the kidney and liver of adult male Wistar rats

Akinpelu Moronkeji, Temidayo Adeniyi, Omokehinde Oseni Akinlami, Firdaws Oriade Alaga, Mofesola Mojisola Adenika
article en
3 citations

Abstract

Phytomedicine, also known as herbal medicine, has seen a great upsurge globally. It refers to the use of plants, herbs, and mixtures of well-known plant metabolites to cure and mitigate human diseases. They are often used because they are natural and therefore assumed to be safer than allopathic medicines. In recent times, however, there has been a growing concern about their safety. This study aimed to evaluate the combined effect of methanolic extract of Rauwolfia vomitoria and Aframomum melegueta on renal and liver morphology of experimental animals with respect to the expression of Interleukin 10 (IL-10) and nuclear factor erythroid 2-related factor 2 (NRF2). Twenty adults male Wistar rats weighing 180-230 g were grouped into four consisting of a control and three test groups. While the control rats were administered with distilled water only, the rats in groups II and III were singly administered with methanolic extracts of Rauwolfia vomitoria and Aframomum melegueta at standard doses of 250 mg/kg/BW respectively while rats in group IV were co-administered with the methanolic extracts of Rauwolfia vomitoria and Aframomum melegueta at 250 mg/kg/BW respectively. At the end of the experiment, the rats were euthanized, and the kidneys and livers were analyzed for histological and mRNA analysis. Histopathological findings revealed no cytopathic lesions on the renal and liver morphology across all groups while mRNA expression studies indicated the anti-inflammatory and antioxidant effects of the plants by upregulating the expression of IL-10 and Nrf-2 in the treated groups. The administration of the leaf extracts of Rauwolfia vomitoria and Aframomum melegueta at a dosage of 250 mg/kg/BW has no cytopathic effects on the kidney and liver morphology of Wistar rats with the co-administrative extract treatment better upregulating the expression of IL-10 and NRF-2 than single administration in the treated rats thus indicating its antioxidative potential and safety of usage and further validating their use in traditional medical practice.

Sokoto Journal of Medical Laboratory ScienceVol. 9(2)
Openalex Percentile: Top 18%
Drug-Induced Hepatotoxicity and Protection
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.